Narayana Hrudayalaya Ltd. — Investor Meet, 24-11-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Narayana Hrudayalaya reported robust Q2 FY26. India operations achieved 20% EBITDA growth from efficiency, advanced surgeries like robotics, and improved payer-mix. Cayman saw 70% revenue growth, with insurance revenue doubling; the Mumbai hospital nears positive EBITDA. CGHS rate hikes are expected to add INR 2-2.5 Cr monthly to India's revenue. Management anticipates significant growth from Cayman's expanding insurance market and efficiency gains from the UK acquisition via technology. New 100 beds in Bangalore are also expected by Q1 FY26. The company maintains a strong focus on clinical excellence and strategic expansion, expressing a confident outlook for future growth.